MedTrace Logo

The Capillary Index Score Trial

NCT02618031 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2020-02-05

Study results available
· View outcomes & findings →

Summary

This study seeks to investigate the capillary index score (CIS) to further improve patient selection of endovascular treatment (EVT) in acute ischemic stroke (AIS).

The hypothesis or idea being tested:

Patients with favorable CIS who are successfully revascularized with EVT can have successful outcomes with an extended time window for treatment.

Conditions

Interventions

PROCEDURE

Endovascular Treatment (EVT)

EVT is an endovascular procedure in which a catheter is inserted into an artery and directed to the site of the blocked blood vessel in the brain. The clot is removed using a mechanical device with or without an injection of tPA (tissue plasminogen activator) directly at the site of the clot. The protocol calls for use of the Trevo stent retriever (Stryker Neurovascular) for the first pass of clot removal.

Sponsors & Collaborators

  • Stryker Neurovascular

    collaborator INDUSTRY

  • Rochester General Hospital

    collaborator OTHER

  • University of Vermont Medical Center

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    collaborator OTHER

  • NYU Langone Health

    collaborator OTHER

  • WellStar Health System

    collaborator OTHER

  • Firas Al-Ali

    lead OTHER

Principal Investigators

  • Firas Al-Ali, MD · Cleveland Clinic Akron General

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2018-08-31
Completion
2018-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02618031 on ClinicalTrials.gov